La deficiencia de carnitina se clasifica en dos grandes grupos, la deficiencia sistmica (que casi nunca se presenta) y la mioptica (la ms corriente)
7.1 Comparing with the conventional hypoglycemic agents Compared with DDP-4i, GLP-1RAs showed better results in reducing the risk of cirrhosis and mortality (Yang et al., 2024)
CYMBALTA showed improvement over placebo on the primary endpoint [change from baseline to end-of-treatment on the Brief Pain Inventory (BPI) Modified Short Form: Adolescent Version 24-hour average pain severity rating] with a p-value of 0.052 from the pre-specified primary analysis, and p-values ranging from 0.011-0.020 from sensitivity analyses which assigned baseline values to missing assessments of some patients who did not complete the trial for various reasons
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test examines predispositions in GLP1R (rs6923761), GIPR (rs1800437), and metabolic variants like FTO and MC4R
Below are the key factors to consider: Both forms are effective, but consulting with a healthcare provider is essential to determine the best option based on your specific needs and goals
